Gene List Selection Matters: Missed Diagnoses in Prenatal Exome Sequencing—PanelApp R21 and HPO‐Driven Versus OMIM‐Based Gene Lists
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Victoria Ardiles-Ruesjas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Research Center, BCNatal, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain. Hauptthemen laut MEDLINE: Exome Sequencing, Prenatal Diagnosis, Missed Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate whether the causative variants found upon clinical exome sequencing in fetuses affected with selected structural anomalies would also be detected if PanelApp‐R21 or Human Phenotype Ontology (HPO)‐driven gene selection terms were applied instead.
Methods
During 9 years (2016–2024), the whole exome was sequenced in 206 pregnancies with selected fetal structural anomalies, with prospective interpretation of about 5000 morbid OMIM genes. Retrospectively, 79 causative and 19 incidental findings were reviewed and assessed for their detectability under two alternative strategies: PanelApp‐R21 or HPO‐driven gene lists.
Results
Among the 79 causative genes identified by interpreting morbid OMIM genes in 78 structurally abnormal fetuses, PanelApp‐R21 was able to detect 76 (96%) genes, while HPO‐driven terms identified only 56 (71%). For 19 incidental findings, the PanelApp‐R21 pathway could identify eight (42%), while HPO terms captured only one (5.3%).
Conclusions
In prenatal ES, reliance on HPO‐driven gene selection significantly lowers diagnostic yield compared with clinical ES, with nearly one‐third of primary findings and most incidental findings missed. PanelApp represents a pragmatic alternative, preserving a high primary diagnostic yield while limiting incidental findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fetal Medicine Research Center, BCNatal, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain.
- Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Catalonia, Spain.
- Biochemistry and Molecular Genetics Department, Biomedical Diagnosis Center, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain.
- CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- Pathology Department, Biomedical Diagnosis Center, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain.
- Department of Basic Clinical Practice, Medicine and Health Sciences School, Universitat de Barcelona, Barcelona, Catalonia, Spain.
ORCID-Profile: Victoria Ardiles-Ruesjas, Laia Rodriguez-Revenga, Montse Pauta, Alfons Nadal, Stiven Ernesto Sinisterra-Díaz, Antoni Borrell
Zitieren
APA
Ardiles-Ruesjas, V., Rodriguez-Revenga, L., Pauta, M., Nadal, A., Arca, G., Gort, L., Sinisterra-Díaz, S. E., & Borrell, A. (2026). Gene List Selection Matters: Missed Diagnoses in Prenatal Exome Sequencing—PanelApp R21 and HPO‐Driven Versus OMIM‐Based Gene Lists. Prenatal Diagnosis. https://doi.org/10.1002/pd.70066
Vancouver
Ardiles-Ruesjas V, Rodriguez-Revenga L, Pauta M, Nadal A, Arca G, Gort L, et al. Gene List Selection Matters: Missed Diagnoses in Prenatal Exome Sequencing—PanelApp R21 and HPO‐Driven Versus OMIM‐Based Gene Lists. Prenatal Diagnosis. 2026. doi:10.1002/pd.70066
BibTeX
@article{ArdilesRuesjas2026,
author = {Ardiles-Ruesjas, Victoria and Rodriguez-Revenga, Laia and Pauta, Montse and Nadal, Alfons and Arca, Gemma and Gort, Laura and Sinisterra-Díaz, Stiven Ernesto and Borrell, Antoni},
title = {Gene List Selection Matters: Missed Diagnoses in Prenatal Exome Sequencing—PanelApp R21 and HPO‐Driven Versus OMIM‐Based Gene Lists},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70066}
}
EUVIMED